Sashidhar Sagi

Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach

Huiping Xu, Z. Kassam, B. Sipe, 2016, Gut microbes.

Bannayan Ruvalcaba Riley Syndrome

Charles J. Kahi, Darren D. Ballard, R. Marks, 2014, ACG case reports journal.

Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.

Siddharth Singh, B. Sands, C. Siegel, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.

Siddharth Singh, B. Sands, C. Siegel, 2018, Inflammatory bowel diseases.

Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Siddharth Singh, B. Sands, C. Siegel, 2018, The American Journal of Gastroenterology.

Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Lose Dose

A. Basit, Sonia C. Timberlake, Z. Kassam, 2018, Digestive Diseases and Sciences.